Poultry Vaccines
Accelerating the Future of Poultry Vaccination
Katalyst Laboratories is proud to distribute an innovative recombinant vaccine platform based on an engineered Newcastle Disease Virus (NDV) vector. This technology provides a safe, stable, and cost-effective solution to protect poultry against major avian diseases, including:
Infectious bronchitis (IBV)
Avian influenza (H5 and H9)
Infectious bursal disease (IBDV)
Newcastle disease (NDV)
With over 70 years of NDV safety data and compatibility with existing egg-based manufacturing infrastructure, this platform enables rapid scale-up without the need for additional capital investment.
Platform Advantages
This NDV-based platform combines proven safety, strong immune protection, and rapid scalability. Built to work seamlessly with existing production methods, it delivers cost-effective vaccines that help safeguard poultry health against multiple major diseases.
Proven vector and safety: NDV has a long record of safety in poultry with natural host restriction.
Synthetic biology design: Codon-pair deoptimisation attenuates virulence while preserving protein function.
Multivalent capability: Supports up to 5.0 kb of antigen inserts with stable replication.
Strong immune response: Induces both antibody and cellular protection in poultry.
Fast to scale: Fully compatible with influenza-style egg production; Vero cell options under exploration for future flexibility.
Vaccine Portfolio
Candidate
NDx-H9
NDx-H5
NDx-IBV
NDx-IBDV
NDx-dual
Target Disease
Avian influenza (H9)
Avian influenza (H5)
Infectious bronchitis
Infectious bursal disease
Newcastle disease
Antigen
H9
H5
S protein
VP2
Dual F genes
Status
Stability & challenge studies completed
Stability & challenge studies completed
Preclinical validation ongoing
Preclinical / challenge studies ongoing
In development
➡️ The platform also supports multivalent formulations for broader protection.
Meeting the Demands of Modern Poultry Production
As global poultry production continues to expand, disease prevention has become increasingly critical to maintaining food security, flock performance, and biosecurity standards. Rising disease pressure and regional outbreak risks are driving demand for faster, more adaptable vaccination technologies.
The recombinant NDV platform addresses these challenges by combining:
- rapid vaccine candidate development
- scalable commercial manufacturing
- strong safety characteristics
- regional adaptability for emerging disease threats
This creates a flexible platform capable of supporting both established poultry vaccination programs and future outbreak-response strategies.
Commercial & Partnership Opportunities
The platform supports a range of commercial applications and strategic partnerships across the global animal health sector, including:
- Regional vaccine distribution partnerships
- Licensing opportunities with animal health companies
- Contract manufacturing collaborations
- Country-specific vaccine deployment programs
- Rapid-response outbreak preparedness initiatives
Its compatibility with existing manufacturing infrastructure helps reduce barriers to adoption while supporting faster commercial deployment.
Summary
Through its distribution of the recombinant NDV vaccine platform, Katalyst Laboratories delivers a scalable and commercially adaptable solution for next-generation poultry health. Designed to support rapid vaccine development while leveraging existing egg-based manufacturing infrastructure, the platform combines a strong safety profile with the flexibility to address both established and emerging avian disease threats.
Explore Partnership Opportunities
Whether you are seeking regional distribution, vaccine development collaboration, or scalable manufacturing solutions, Katalyst Laboratories can support the deployment of advanced recombinant poultry vaccine technologies.
Why Choose Katalyst Laboratories for Your Microbiology and Virology Diagnostic Solutions?
High-Quality Reagents and Equipment
Providing advanced diagnostic solutions for microbiology and virology. Our CE IVD and qPCR assays are designed to deliver precise, reliable, and timely results, empowering healthcare professionals to make informed decisions.
Commitment to Quality
Our product portfolio undergo rigorous testing and continuous review to ensure they meet the highest standards of specificity and sensitivity.
Innovative and Reliable Testing
Flexibility and Convenience
Sustainable Practices
CONTACT US
We’d love to hear from you.
Please send a brief summary of your project and requirements and we’ll be in touch to discuss further.